Back to Results
First PageMeta Content
Mitsubishi / Glucagon-like peptide-1 / Economy of Asia / Mitsubishi companies / Mitsubishi Pharma / Dipeptidyl peptidase-4 inhibitors / Economy of Japan / Daiichi Sankyo / Chūō-ku / Osaka


June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets
Add to Reading List

Document Date: 2012-09-04 21:13:37

Open Document

File Size: 34,92 KB

Share Result on Facebook

City

Tokyo / Osaka / /

Company

Daiichi Sankyo Co. Ltd. / Mitsubishi Tanabe Pharma Corporation / /

Country

Japan / /

Event

FDA Phase / /

IndustryTerm

food ingestion / manufacturing / /

MedicalCondition

diabetes mellitus / disease / /

Person

Michihiro Tsuchiya / Joji Nakayama / /

/

Position

President & Representative / Head Office / President & CEO / Director / /

Product

glucagon / 20mg / Japan / TENELIA® / /

SocialTag